-The Telegraph The Supreme Court has said it wants to end judicial monitoring of social welfare schemes, saying the task should be left to experts and courts “can’t be setting economic policy”. The court had earlier taken umbrage at the government for fixing the poverty line at a measly Rs 32 per day per person in urban areas and suggested free distribution of foodgrain, causing consternation in the government which felt that...

-The Telegraph The Supreme Court today took cognisance of a public interest petition about alleged extra-judicial killings of unarmed nationals by the Border Security Force along the Bengal stretch of the border with Bangladesh. A two-judge bench of Justices K.S. Radhakrishnan and Dipak Mishra issued notices to the Centre and the Bengal government after hearing short arguments from senior counsel Colin Gonsalves for the Banglar Manabadhikar Suraksha Mancha, an NGO that filed...

-The Business Standard Still waiting for a crackdown on antibiotic over-prescription According to a recent study in the Lancet Infectious Diseases journal, the drug-resistant bacterial strain known as New Delhi metallo-beta-lactamase 1, or NDM-1, has spread to 40 countries. This is quite remarkable, given that it was only discovered in 2008 in the UK, among patients who had recently been hospitalised in India. The “superbug”, as it is commonly known, is...

There has been a six-fold increase in the number of antibiotics being popped by Indians. This includes the retail sale of Carbapenems -- powerful class IV antibiotics, typically used as a "last resort" to treat serious infections caused by multi-drug resistant, gram-negative pathogens. Research by the Centre for Disease Dynamics, Economics and Policy, Washington DC, has found that retail sale of carbapenems increased six times -- from 0.21 units per million...

-The Hindu Business Line The onus of granting approvals to medicines marketed in the country is on the regulator Drug Controller General of India (DCGI), say drug companies, adding that they have adhered to the law of the land. The drug-makers were responding to a Parliamentary panel report on health that severely indicted the drug regulatory authority, besides alleging that “invisible hands” of drug-makers were involved in getting favourable reports on medicines...